GEODE CAPITAL MANAGEMENT, LLC
Position in TARS — Tarsus Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in TARS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$69,592,065
-$9,052,468 QoQ
Shares Held
1,105,689
-1.4% QoQ
Ownership
2.52%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. TARS ranks #66 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,592,065 | 1,105,689 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $78,644,533 | 1,121,091 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $77,602,833 | 947,763 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $56,131,396 | 944,496 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $37,853,353 | 934,420 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $44,457,343 | 865,434 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $46,444,576 | 838,804 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $27,489,132 | 835,790 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $21,016,526 | 773,235 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $22,889,304 | 629,692 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $12,347,154 | 609,736 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,351,640 | 526,260 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,038,638 | 444,861 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,388,802 | 349,149 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,001,860 | 341,191 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,640,714 | 329,481 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,884,826 | 266,084 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,199,349 | 130,758 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,830,837 | 125,815 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,665,691 | 123,698 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,637,598 | 125,521 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,281,304 | 101,809 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,561,798 | 110,375 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||